secwatch.observer — SEC 8-K summary
======================================

Issuer:     SkinHealth Systems Inc. (SKIN)
CIK:        0001818093
Form:       8-K
Filed at:   2024-08-08T23:59:59+00:00
Accession:  0001628280-24-036121
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BeautyHealth Q2 net sales down 23% YoY to $90.6M; revises full-year guidance
----------------------------------------------------------------------------

- Net sales $90.6M, down 22.9% YoY; equipment sales fell while consumables grew 6.7%.
- Delivery systems sold 1,285 vs 2,822 in Q2 2023; active install base grew to 33,504 (+13%).
- Adjusted EBITDA loss $5.2M vs positive $12.4M last year; adjusted gross margin 49.4% vs 64.5%.
- Operating expenses improved nearly $18M YoY; company cites cost efficiency.
- Full year 2024 guidance revised downward, citing slower device recovery and macro pressures.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818093/000162828024036121/0001628280-24-036121-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818093/000162828024036121/skin-20240808.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-036121

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer